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Abstract: Intrinsic cell death is mediated by interaction between pro-apoptotic and pro-
survival proteins of the B-cell lymphoma-2 (Bcl-2) family. Members of this family are 
either intrinsically disordered or contain intrinsically disordered regions/domains that are 
critical  to  their  function.  Alternate  splicing  and  post-translational  modifications  can 
determine  the  extent  of  these  disordered  regions  and  are  critical  for  regulating  Bcl-2 
proteins. Conformational plasticity and structural transitions characterize the interactions 
within the Bcl-2 family, with conserved sequence motifs on both binding partners required 
for their molecular recognition. 
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1. Introduction 
In  response  to  intra-cellular  stress  signals  cells  initiate  a  programmed  cell  suicide  known  as 
apoptosis.  Members  of  the  Bcl-2  family  of  proteins  are  critical  to  the  regulation  of  ‘intrinsic’  or 
mitochondrial  initiated  cell  death  [1].  The  Bcl-2  family  consists  of  members  that  either  promote 
apoptosis,  the  pro-apoptotic  proteins,  or  those  that  inhibit  this  action,  the  pro-survival  proteins. 
Protein-protein interactions between these opposing factions mediate the life/death switch and it is 
thought the balance between the pro-survival and pro-apoptotic proteins decides cell fate [2]. As might 
be expected, their role as caretakers of cell fate ensures that the Bcl-2 family is highly regulated by a 
plethora of transcriptional, translational and post-translational mechanisms. 
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The sequence identity shared between members of the Bcl-2 family ranges between 3 and 40% but 
is typically <20%. Bcl-2, Bcl-xL and Bcl-w are the most similar with Bcl-2/Bcl-xL having 39.9% 
sequence identity. Among the BH3-only proteins Bim and Bmf have 20.4% shared identity, while the 
multi-motif pro-apoptotic protein Bax and BH3-only protein Hrk share only 3.2% identity. Although 
the sequence identity shared in the Bcl-2 family is low they all  bear conserved sequence regions 
known as Bcl-2 homology (BH) domains or motifs and harbor up to four of these regions, BH1-BH4. 
The BH motifs are functionally important and underpin the interaction between Bcl-2 proteins [3]. The 
pro-apoptotic proteins either bear a single BH domain, the BH3-motif, and are known as the BH3-only 
proteins  (members  of  this  group  include  Bim,  Bad,  Bmf,  Bid,  Bik,  Puma,  Noxa  and  Hrk)  or are 
structurally homologous to the pro-survival proteins Bcl-2, Bcl-xL, Bcl-w, Bcl-B, Bfl-1, and Mcl-1 and 
and are known as the multi-motif Bax-like proteins (Bax, Bak and Bok) [3] (Figures 1 and 2). In 
addition to bearing BH domains, Bcl-2 family proteins frequently have hydrophobic residues at their 
C-termini,  identified as  the ‘trans-membrane’ (TM)  motif, which  are important for localization  to 
intra-cellular membranes such as the mitochondrial outer membrane (MOM), endoplasmic reticulum 
and the nuclear envelope [4]. 
Figure  1.  General  scheme  showing  the  role  of  the  Bcl-2  family  in  ‘intrinsic’  or 
mitochondrial activated apoptosis. The BH3-only protein Bid links cell death receptor 
(‘extrinsic’)  signaled  apoptosis  to  intrinsic  apoptosis.  Bid  is  activated  by  proteolytic 
cleavage by caspase-8 in its IDR. 
 
 
In mammals, the Bcl-2 proteins control the integrity of the MOM by a still poorly characterized and 
controversial mechanism [5]. The BH3-only proteins act as the cellular sentinels that are activated in 
response to an apoptotic stimulus and they initiate the apoptotic process by binding in a hydrophobic 
groove located on the surface of the pro-survival proteins. This interaction liberates the pro-apoptotic 
Bax-like  proteins,  which  effect  apoptosis  by  releasing  factors  such  as  cytochrome  c  from  the Int. J. Mol. Sci. 2010, 11                       
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mitochondrial inter-membrane space into the cytosol (Figure 1). Gene knockout studies have shown 
that intrinsic apoptosis is dependent on the presence of Bax-like proteins and deletion of bax and bak 
render cells resistant to apoptotic stimuli [6]. Once released, cytochrome c interacts with cytosolic 
scaffold  proteins  promoting  dimerization  and  activation  of  caspases,  cysteine  aspartyl  proteases. 
Activated caspases execute a proteolytic cascade and destroy the cell from within, leading to its death, 
breakdown and phagocytosis [1].  
Figure 2. The Bcl-2 family of proteins and their mode of action. (a) The Bcl-2 family is 
split by structure and sequence into two groups: the multi-motif proteins that includes both 
pro-survival (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, A1, Bcl-B) and pro-apoptotic members (Bax, 
Bak, Bok) that have an all helical Bcl-2 fold with IDRs and the IDP BH3-only proteins that 
only have a single BH3 motif (Bim, Bad, Bmf, Bid, Puma, Bik, Noxa, Hrk). The colored 
bars indicate the extent of helices and the location of BH motifs is indicated by black bars 
(b) Scheme showing the mode of Bcl-2 family action. The BH3-only proteins inhibit the 
pro-survival action allowing the Bax-like proteins to permeablize the mitochondrial outer 
membrane releasing cytochrome c to activate the caspase cascade that destroys the cell. 
 
 
Aberrant  regulation  of  apoptosis  has  been  directly  linked  to  many  diseases  and  is  one  of  the 
hallmarks of cancer [7]. The Bcl-2 family proteins key role in determining cell fate has led to an 
intensive effort to understand their mode of action with the aim of therapeutic intervention [8]. These 
studies have uncovered important roles for unstructured motifs with the action of the Bcl-2 family as 
well as many of their up- and down-stream effectors, depending upon residues that do not have well-
defined  conformation.  In  addition  covalent  modification  of  BH3-peptides  is  being  used  to 
conformationally restrict these peptides to improve their in vivo proteolytic stability and the potency 
against tumors to explore their utility in cancer treatments [9]. Here we review the roles of intrinsically 
disordered proteins (IDPs) and intrinsically disordered regions (IDRs) and their interactions in the  
Bcl-2 family. 
2. Bcl-2 Proteins Are IDPs, or Contain IDRs 
The first structures in the Bcl-2 family became available over a decade ago [10–12] and a number 
of Bcl-2 structures and their complexes have since been solved. These have recently been incorporated 
into a sequence-structure database, BCL2DB [13]. The solution structure of C-terminally truncated 
Bcl-xL [10] revealed a helical bundle structure with a long inter-helical loop of ~60 residues that 
connects  helices  1  and  2.  The  Bcl-xL  structure,  as  well  as  structures  of  other  Bcl-2  proteins, Int. J. Mol. Sci. 2010, 11                       
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demonstrated that both the pro-survival and Bax-like proteins share this helical fold, now described as 
the Bcl-2 fold. The Bcl-2 fold consists of a helical bundle where 7 amphipathic helices (1-4, 6-8) 
pack against a central solvent inaccessible hydrophobic helix (5) [3] (Figure 3). In addition Bax [14] 
and Bcl-w [15,16], that were obtained as soluble proteins without requiring such extensive truncation 
of  their  C-terminal  residues,  bear  a  ninth  helix  (9),  containing  the  TM  region,  that  lies  in  a 
hydrophobic groove created by helices 2-5 and 8. Biochemical data suggested that the TM region 
blocks access to the binding site in other pro-survival proteins [16]. Disordered residues are found in 
the long 1-2 inter-helical loop of Bcl-2 and Bcl-xL, other multi-motif Bcl-2 proteins have a short 
mobile  loop  of  approximately  12  residues  in  the  corresponding  position.  Uniquely,  Mcl-1  has  an 
extended N-terminal region predicted to be unstructured and this region of ~160 residues [17] contains 
regulatory elements such as two PEST sequences [18], (sequences enriched in proline [P], glutamic 
acid  [E],  serine  [S]  and  threonine  [T]  [19]),  which  are  in  part  responsible  for  regulating  its  
degradation [20]. 
In  contrast  to  their  pro-survival  and  Bax-like  relatives  the  BH3-only  proteins  lack  long-range 
structure  [21].  Sequence  analysis,  circular  dichroism  (CD),  nuclear  magnetic  resonance  (NMR) 
spectroscopic studies and biochemical evidence such as proteolytic susceptibility demonstrate that the 
BH3-only proteins are IDPs and even in the presence of their binding partners only the short BH3-
motif has a defined structure [21,22]. Bid differs from other BH3-only proteins and has a Bcl-2 like 
fold structure with an IDR of 43 residues connecting helices 1 and 2 [23,24]. However, Bid is 
activated by proteolytic cleavage at a conserved site within the 1-2 loop to generate a p7 and p15 
fragment of 7 and 15 kDa respectively. The C-terminal p15 fragment of Bid is known as truncated Bid, 
or tBid and contains the BH3 motif. tBid has partial -helical secondary structure, but it is in dynamic 
conformational exchange consistent with a molten globule state [25]. tBid is thus an example of an 
IDP that can be generated by post-translational modification of a folded protein. 
3. Structural Transitions Characterize Bcl-2 Interactions 
One  of  the  central  features  underlying  interactions  in  the  Bcl-2  family  is  their  conformational 
mobility [3]. The BH3-motif of IDPs like Bim, Bad, Bmf and tBid folds into an -helix on binding in a 
hydrophobic groove formed from residues in helices 2-5 and 8 on the pro-survival protein [11] 
(Figure 3). The exact intermolecular contacts and changes in geometry of the partners upon interaction 
are  dependent  on  the  specific  components  of  the  complex  [17,26].  In  the  uncomplexed  state,  the 
groove of Bcl-xL is in a closed state with 3 and 4 well-formed helices that are parallel and closely 
packed  [22].  On  binding  Bim,  helix  4  of  Bcl-xL  rotates  to  accommodate  the ligand  and  the  3 
residues no longer form a regular -helix [22]. In contrast, Mcl-1 has a binding site that is similar in 
the presence and absence of the ligand [27,28]. 
Although the exact interactions between BH3-only proteins and their pro-survival binding partners 
vary between complexes, a number of common features are apparent due to the presence of the 13 
residue motif, 1sxx2xx3sDz4B in all ligands. The conserved leucine at position 2 and aspartic 
acid residue at position D defines the BH3 motif [27]. The four hydrophobic residues, 1-4, form a 
hydrophobic surface on the amphipathic BH3-helix. The other positions are: x is any residue, s small 
residues (G, A or S), z is normally an acidic residue and B a hydrogen bond acceptor. This short Int. J. Mol. Sci. 2010, 11                       
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peptide motif binds and folds as an amphipathic helix in the hydrophobic groove of the pro-survival 
protein burying the hydrophobic residues  1–4 in the interface. The conserved aspartic acid, D, 
forms a salt bridge with a conserved arginine in the BH1 motif of the pro-survival protein. Analysis of 
Bim and tBid binding to Bcl-w [21] and Bcl-xL [25] show that helical structure is only induced over 
the BH3 motif and outside this region the sequence remains poorly ordered. 
Figure  3.  Structures  of  pro-survival  proteins  and  their  BH3-only  complexes.  
(a)  Ribbon  diagram  of  Bcl-w  (PDB:  1O0L)  [16].  The  helices  are  labelled  1-9.  
(b). Ribbon diagram of unliganded C-terminally truncated Mcl-1 (1WSX) showing the 
binding groove [17]. (c) The BH1, BH2 and BH3 motifs are brought into close proximity 
on  Mcl-1  by  the  Bcl-2  fold  of  the  pro-survival  proteins  to  provide  a  surface  exposed 
hydrophobic  groove  that  binds  the  BH3  motif  of  a  BH3-only  protein  as  an  -helix.  
(d) The IDP Noxa bound in the groove of Mcl-1 (2ROD) [27]. (e) Schematic of BH3-only 
protein binding a pro-survival protein. The BH3-only proteins are IDPs that displace a 
structured C-terminal helix to bind and fold in a hydrophobic groove of the pro-survival 
protein. This displacement generates an IDR at the C-terminus of the pro-survival protein. 
 
 
Using a conformationally restricted Bim peptide, that maintained a higher helical propensity and 
affinity  than  the  unmodified  BH3-peptide,  it  was  discovered  that  Bim  binds  Bax  through  its 
hydrophobic  surface  [29].  Curiously,  although  Bax  is  structurally  homologous  to  the  pro-survival 
proteins [14] the Bim binding site was not mapped to the equivalent binding groove, but rather to the 
opposite face. The Bim binding surface on Bax was provided by helices 1 and 6 and there was little 
change in the Bax conformation on binding Bim. The surface provided by 1 and 6 on Bax does not 
rely on interaction with highly conserved residues like the groove and demonstrates the potential of 
multi-motif proteins to provide alternate binding surfaces and the BH3-only protein to adapt to these 
surfaces. Bax is normally cytosolic but localizes to mitochondria on initiation of apoptosis [30]. Bim 
binding Bax may provide the trigger that activates this translocation [29]. Int. J. Mol. Sci. 2010, 11                       
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The C-terminal TM helix of Bcl-w, 9, like that of full-length Bax [14] lies in the hydrophobic 
groove used by the pro-survival proteins to bind their pro-apoptotic counterparts [15,16]. Binding a 
BH3-only  protein  displaces  the  C-terminal  residues  from  the  groove  of  Bcl-w  and  they  become 
unstructured in solution [15,16] forming a new IDR (Figure 3). The ligand induced order-disorder 
transition of the TM residues appears to be driven by a disorder-order transition in the BH3 motif of 
the ligand and may be the initial step that leads to membrane integration of the pro-survival protein. 
The TM residues are necessary for correct localization to the membrane on BH3-only protein binding 
[31] and studies suggest correct localization is critical as Bcl-w is not fully protective in their absence, 
even though binding to BH3-only proteins is retained [16]. 
4. Bcl-2 Protein Structural Plasticity and Multiple Binding Partners  
BH3-only proteins have a striking ability to interact with the binding grooves of multiple pro-
survival proteins [32–34]. Like other protein-protein interactions those between an IDP and structured 
protein are entropy-enthalpy compensated [27] indicating that solvation plays an important role in 
binding [35]. While some BH3-only proteins bind all pro-survival proteins with approximately equal 
(high) affinity, others bind only selected pro-survival proteins and their capacity to promote apoptosis 
is limited [34]. The binding affinities can be remarkably tight, with dissociation constants typically in 
the nanomolar range [26,27,34]. Coupled folding and binding of IDPs provides a mechanism that fine 
tunes binding specificity to multiple targets. Conformational mobility permits local conformational 
adaptation for binding [36,37] and the ability of BH3-only proteins to engage multiple binding partners 
is in part due to their significant structural plasticity [17,26]. Bid, Puma and Bak BH3-peptides bind 
A1 with dissociation constants, Kd < 1–3 nM, while Bmf has an approximately 100 fold lower affinity 
with a Kd of 180 nM [26]. The majority of the intermolecular contacts for these four A1 complexes are 
identical.  The  highly  conserved  BH3  leucine  and  invariant  aspartate  of  the  BH3  motif  make  key 
contacts. The leucine is buried in a hydrophobic pocket provided by a cluster of highly conserved 
hydrophobic residues, while the aspartate makes a salt bridge with the conserved arginine in the BH1 
motif. In the case of the low affinity A1:Bmf interaction the Bmf-BH3-motif packs in the binding 
groove tightly, but strikingly, the inter-molecular salt-bridge with the conserved aspartate is absent, 
instead it forms an intra-molecular salt bridge with a nearby arginine [26]. The importance of the salt 
bridge for high affinity interactions was also demonstrated for interaction of Bak BH3-peptide with 
Bcl-xL,  where  mutation  of  the  aspartate  in  Bak  BH3  lead  to  significantly  weaker  binding  [11]. 
Therefore, although hydrophobic contacts are important, charged and hydrogen bonding also play an 
important role in BH3 interactions. 
Several studies have indicated the importance of the conformational mobility of the pro-survival 
protein binding groove and pro-survival proteins are tolerant of sequence changes in the BH3-ligand. 
For example, Mcl-1 tolerates a wide range of residues at the 1 position of the BH3-motif while Bcl-
xL does not [27,38]. Novel peptide sequences selective for Mcl-1 were identified using phage display 
that showed Mcl-1 could tolerate some degree of change from the canonical BH3-sequence [39]. The 
interaction of Mcl-1 with Noxa illustrates that the sequence composition of the groove also contributes 
to selective BH3 binding. Mouse Noxa has two BH3-motifs differing at the N-terminal 1 residue, the 
C-terminal BH3 (NoxaB) has a glutamic acid residue instead of the usual hydrophobic residue. NoxaB, Int. J. Mol. Sci. 2010, 11                       
 
 
 1814 
binds Mcl-1 but not A1, while the N-terminal Noxa-BH3 motif (NoxaA) has the usual hydrophobic 
residue at 1 and binds both A1 and Mcl-1 [27]. The Mcl-1 has a conserved basic patch in the 3-4 
loop that can compliment the negatively charged acidic residue E74, while in A1 at the structurally 
equivalent position has acidic residues (Figure 4). On binding ligand similar structural changes are 
induced in Mcl-1 that are almost independent of the particular BH3 peptide ligand bound [27] and 
mutant Bim BH3 ligands bound tightly to Mcl-1 with only minor structural changes to Mcl-1 [40]. 
Point mutations to groove residues on the BH3-binding binding surface of Mcl-1 had little effect on 
Bim binding [17]. Each of the pro-survival proteins appears to have subtly different binding grooves 
and the combination of the dynamics of the unstructured ligand and those of the receptor pro-survival 
protein  determine  their  selectivity  and  affinity.  The  ability  of  IDPs  and  their  receptors  to  form 
alternative inter-molecular contacts is an important characteristic of their interactions. 
Figure 4. Close-up view of differences between the A1 and Mcl-1 grooves. (a) The 
presence of a basic patch provided by residues R214 and K215 in the 3-4 loop in Mcl-1 
accommodates  the  presence  of  an  acidic  residue  (E74)  in  the  BH3  domain  of  mouse 
NoxaB  (PDB:  2NLA)  [27].  (b)  The  same  view  of  the  Mcl-1:NoxaA  complex  (PDB: 
2ROC)  where  a  hydrophobic  residue  (F23)  occupies  a  similar  position  to  E74  in  (a).  
(c) An acidic patch formed by residues D57 and D58 occupies the structurally equivalent 
position in A1 (PDB: 2VOF) to the basic patch in Mcl-1. NoxaB does not bind A1 [26]. 
The ribbon of the BH3 ligand is colored yellow. Basic residues are shown in blue and 
acidic residues in red. 
 
5. Alternate Splicing Leads to Structural Diversity 
Alternate splicing is an important regulation mechanism in the Bcl-2 family and not only regulates 
Bcl-2  protein  levels  but  also  their  interactions.  New  molecular  species  are  generated  by  alternate 
splicing that have modified structures and biological behavior. The presence of multiple splice variants 
for  most  Bcl-2  family  members  [41]  increases  the  complexity  of  apoptosis  signaling.  The  pro-
apoptotic signal of the BH3-only proteins is contained within the short ~16 residue BH3-motif [42] 
and exists on a single exon [43]. Most, if not all, BH3-only proteins like Bim [44–46], Bid [47], Bad 
[48,49], Bmf [50,51], Puma [52] and Noxa [53] have multiple splice variants. Regions flanking the 
BH3 motif in BH3-only proteins do not appear necessary for either pro-survival protein binding or 
specificity as the BH3 segment has essentially the full binding affinity for the pro-survival target [31]. 
Notably, peptides that span the BH3 motif bind with affinities and specificities [34] that predict the 
biology [54]. Int. J. Mol. Sci. 2010, 11                       
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Three major splice variants of Bim have been observed; BimS, BimL and BimEL, the short, long and 
extra  long  isoforms  respectively  and  all  are  capable  of  initiating  apoptosis  [44,45]  (Figure  5). 
Sequence analysis indicates all are IDPs [21] and all three isoforms bear the BH3-motif that is encoded 
by exon 8, however they have different activities depending on the other exons translated. BimL and 
BimEL, for instance, have the binding site for the dynein motor complex protein dynein light chain 1 
(DLC1) and are regulated by interaction with this protein [55]. Bmf also associates with a motor 
complex through binding a dynein light chain [56], but associates with the myosin V motor complex 
through binding DLC2 [57]. This interaction occurs through a short motif, (K/R)XTQT (X is any 
residue)  [58]  located  on  exon  4  that  forms  a  complementary  anti-parallel  -strand  extending  the  
-sheet  of  the  DLC  protein.  Association  of  Bmf  and  Bim  with  their  respective  DLC  proteins 
compartmentalizes them [57] and like BimS the exon that encompasses the DLC binding motif in BmfS 
is not translated [51]. In addition to the three main isoforms of Bim, there are numerous other mRNA 
transcripts some of which are missing key exons but it is unclear if they are all translated to proteins 
[59]. At least three splice variants of Bid are known, and all would be expected to be IDPs like tBid, 
[47],  yet  they  differ  in  their  expression  patterns,  localization,  regulation  and  apoptotic  initiation. 
Unlike their structured counterparts IDPs are not reliant on a tertiary structure for their functionality 
and could be considered molecular ‘cut and paste’ frameworks. The unstructured nature of BH3-only 
proteins  means  that  the  splice  variants  can  retain  selected  functionality  and  their  prevalence  may 
regulate specific apoptotic pathways. The development of unstructured regions through splice variants 
allows structure-independent changes in function that can modulate these molecules and impact on 
their ability to initiate apoptosis.  
Figure 5. Splice variants and post-translational modification sites in Bim. The BH3 
motif in the BH3-only proteins occurs on a single exon while the same region is shared 
with other motifs in the multi-motif proteins. The three main splice variants, short, long 
and extra long of Bim differ in exons 3 and 4. The corresponding sequence position is 
given above the bar and the exons are indicated. Marked on exon 4 is the DLC binding 
domain (DBD, hatched) and on exon 8 circles indicate the extent of the binding region of 
the BH3 motif. The potential phosphorylation sites are indicated with P and ubiquitylation 
sites with U. 
 
 
The BH1-BH3 motifs, or equivalent regions, in the pro-survival Bcl-2 proteins constitute the BH3-
ligand binding surface and are required for their pro-survival activity [3]. Alternate splice variants of 
the multi-motif Bcl-2 proteins Bcl-2, Bcl-xL, Mcl-1, Bfl-1, Bax and Bok have been reported [41]. The 
BH3 motif is located on a single exon for Bax, Bak and Mcl-1, potentially making them targets of 
exon shuffling [43] while, in the case of Bok, it is split between two exons. In other multi-motif Int. J. Mol. Sci. 2010, 11                       
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proteins either the BH1 or BH4 motif is found on the same exon as the BH3 motif. Many splice 
variants of these proteins lack the BH1 and BH2 motifs, but retain the BH3 motif. These proteins are 
therefore likely to lack a tertiary structure and may be pro-apoptotic by virtue of their exposed BH3 
motifs. For example, Mcl-1S, a ‘short’ splice variant of Mcl-1, retains the N-terminal unstructured and 
BH3  motifs,  but  lacks  the  BH1,  BH2  and  TM  motifs  [60].  In  contrast,  the  ‘extra  short’  variant,  
Mcl-1ES retains BH1, BH2, BH3, the N-terminal residues and hydrophobic C-terminal region, but 
lacks the unstructured PEST sequences [61]. Mcl-1S and Mcl-1ES have been reported to have pro-
apoptotic activity [39,60]. Alternate splicing thus provides an attractive mechanism for exposure of the 
BH3 motif and generation of an IDP with an altered apoptotic function.  
In the case of Bax, a splice variant, Bax, has an extended C-terminal sequence that not only 
couples  Bax  to  proteasomal  degradation  pathways  but  also  renders  it  a  more  potent  killer  [62]. 
Splicing  sites  are  generally  more  prevalent  within  IDRs  as  a  splicing  event  within  an  IDR  will 
minimize its effect on structured regions but broadens the functional and regulatory diversity [63]. 
However, not all splice sites fall in IDRs and a recent analysis indicates that many are located in 
structured regions and this may be a means of producing isoforms with new functional roles [64].  
6. Generating New IDRs and Reactivity through Post-translational Modification 
IDP levels are tightly controlled in the cell and kept at low levels by a combination of low protein 
synthesis and rapid degradation [65]. The control of protein activity and stability by post-translational 
modification is an important regulatory mechanism in apoptosis [66]. Characterized modifications in 
the  Bcl-2  family  include  phosphorylation,  ubiquitylation,  caspase  cleavage  and  deamidation  [67]. 
These modification sites are largely confined to the IDRs, indicating the importance of these regions in 
regulating protein function. 
Bim  and  Bad  illustrate  the  complexity  of  post-translational  control  of  BH3-only  proteins  and 
indicates their ability to interact with multiple post-translational modifying proteins. In a healthy cell 
Bad is inactivated by phosphorylation at multiple sites (see [67] for a summary) and sequestered to 
cytoskeletal 14-3-3 proteins that inhibit its action [68]. Many kinases (such as PKA, Akt/PKB or RSK) 
can  phosphorylate  and  inactivate  Bad  and  conversely,  phosphatases  (such  as  calcineurin),  can 
dephosphorylate and reactivate its pro-apoptotic activity [69,70]. Phosphorylation by JNK at specific 
serines activates Bad by inhibiting its interaction with 14-3-3 proteins [71,72], but phosphorylation at 
other serines lowers its pro-apoptotic activity although it retains the ability to interact with Bcl-xL [73]. 
Like Bad, post-translational modification at multiple sites modulates Bim activity (Figure 5) and each 
isoform may be differentially modified [74,75]. The proline directed kinase ERK1/2 phosphorylates 
BimEL at multiple sites on exon 3 (Figure 5) targeting it for proteasomal degradation [76] while the 
absence  of  the  same  exon  in  BimS  and  BimL  renders  these  isoforms  less  sensitive  to  ERK1/2 
phosphorylation [74,75,77]. The kinase Akt also phosphorylates BimEL on exon 3, but at a site separate 
from that of ERK1/2, reflecting its different specificity [78]. Akt phosphorylated-Bim can bind 14-3-3 
proteins and this ablates its pro-apoptotic activity [78]. Therefore depending on the cellular context, 
multiple post-translational events can regulate the activity of Bim, Bad and other BH3-only proteins 
requiring their interaction with multiple proteins. Int. J. Mol. Sci. 2010, 11                       
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Activation of Bid occurs by proteolytic cleavage at conserved sites in its 1-2 IDR by proteases 
such as caspase-8 and Granzyme B, the latter used in the immune response by killer T-cells to activate 
intrinsic apoptosis to eliminate infected cells [79]. The proteolytic cleavage generates an IDP capable 
of  neutralizing  the  activity  of  pro-survival  proteins.  In  addition  to  exposing  its  BH3  motif  for 
interaction  with  pro-survival  Bcl-2  partners  [25],  caspase  cleavage  of  Bid  generates  a  potential 
myristoylation site at the newly generated N-terminal glycine residue of tBid that may trigger its 
mitochondrial translocation [80] and ultimately the permeabilization of the MOM [81]. In contrast, 
phosphorylation of other sites in the IDR of Bid by both casein kinases I and II has been shown to 
prevent cleavage by caspase-8 and protect against death receptor induced apoptosis [82].  
Although  characterized  by  their  Bcl-2  helical  bundle,  the  multi-motif  Bcl-2  proteins  also  have 
IDRs. These unstructured regions present sites for conserved post-translational modifications that may 
either inhibit or promote apoptosis [67]. Regulatory functions have been ascribed to the 1-2 IDR of 
Bcl-xL and Bcl-2 [83] and phosphorylation [84,85], deamidation [86] and proteolyic cleavage [87,88] 
in  this  region  have  all  been  associated  with  down  regulation  of  pro-survival  activity.  Similarly, 
modification of residues in the IDR of Mcl-1 by proteolytic cleavage, phosphorylation or ubquitylation 
transforms its apoptotic activity [89]. Apart from the first 20 residues of Mcl-1 its IDR is variable [20], 
but the PEST sequences in the IDR are conserved and enhance its degradation contributing to its short 
half-life (1–5 h) [20,90]. In comparison, Bcl-2 has a half-life of ~20 h [91]. In response to apoptotic 
stimuli Mcl-1 is rapidly upregulated and post-translational mechanisms are in part responsible for 
temporal control of protein levels [92]. Ubiquitin proteasome-mediated degradation also regulates the 
activity of Bcl-2, Bcl-xL and Mcl-1 and ubiquitin modified lysines in Mcl-1 have been mapped to the 
N-terminal IDR and 1-2 disordered loop [67,93]. 
The examples given above demonstrate the complexity of Bcl-2 family regulation through post-
translational  events.  All  members  of  the  Bcl-2  family  bear  conserved  sites  for  post-translational 
modification in unstructured regions that regulate their activity. These post-translational modifications 
connect apoptosis to other signaling pathways such as those signaled through MAP kinase [94] and 
also  have  the  capability  to  interact  with  multiple  other  modifying  proteins.  Post-translational 
modification  generates  new  molecular  species  with  different  interaction  profiles  and  modified 
biological activity. Most post-translational modifications are still poorly characterized with neither the 
modification  sites,  temporal  control  nor  the  physiological  context  in  which  specific  mechanisms 
prevail is clear. However, the crucial role of these modifications in regulating intrinsic apoptosis is 
unambiguous.  
7. Conclusions 
Unstructured regions play important roles in every aspect of Bcl-2 regulated apoptosis. All Bcl-2 
family members either contain IDRs, like Bcl-2, Bcl-xL and Mcl-1, or are IDPs, such as Bim, Bad and 
Bmf. The unstructured regions of Bcl-2 proteins are targets for post-translational regulation through 
interaction with enzymes that regulate their levels and capacity to interact with other members of the 
Bcl-2 family. Although the significance of many aspects of the post-translational modifications have 
yet  to  be  established,  collectively  the  multiplicity  of  regulatory  processes  that  act  through  the 
unstructured regions of the Bcl-2 family attests to their importance in controlling Bcl-2 activity. The Int. J. Mol. Sci. 2010, 11                       
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unstructured regions allow recognition by other proteins that is highly specific, but of low affinity. A 
key  interaction  regulating  apoptosis  that  has  been  well  investigated  is  that  between  pro-survival 
proteins and their BH3-only counterparts which fold and bind tightly as a helix within the groove of a 
pro-survival protein. Although it is thought hydrophobic interactions are overriding for IDPs [95], 
polar interactions make significant contributions to BH3-only binding [27]. The unstructured nature of 
the  BH3-only  proteins  and  their  tight  regulation  is  consistent  with  their  position  as  initiators  in 
apoptotic pathways and many have the ability to act promiscuously. This promiscuity coupled with 
protein  compartmentalization,  splice  variation,  post-translational  modifications  and  degradation 
increases the complexity in cell death signaling and is likely to reduce the chance of inadvertently 
initiating a fatal signaling event [65]. Together, the interplay between the unstructured and structured 
components of the Bcl-2 family is crucial for determining cell fate.  
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